These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 31337396)

  • 1. Impact of public hospital pricing reform on medical expenditure structure in Jiangsu, China: a synthetic control analysis.
    Zang X; Zhang M; Wei S; Tang W; Jiang S
    BMC Health Serv Res; 2019 Jul; 19(1):512. PubMed ID: 31337396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Chinese medical pricing reform on the structure of hospital revenue and healthcare expenditure in county hospital: an interrupted time series analysis.
    Liu M; Jia M; Lin Q; Zhu J; Wang D
    BMC Health Serv Res; 2021 Apr; 21(1):385. PubMed ID: 33902578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impacts and unintended consequences of the nationwide pricing reform for drugs and medical services in the urban public hospitals in China.
    Zhang X; Lai H; Zhang L; He J; Fu B; Jin C
    BMC Health Serv Res; 2020 Nov; 20(1):1058. PubMed ID: 33225941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving the performance of social health insurance system through increasing outpatient expenditure reimbursement ratio: a quasi-experimental evaluation study from rural China.
    Miao Y; Gu J; Zhang L; He R; Sandeep S; Wu J
    Int J Equity Health; 2018 Jun; 17(1):89. PubMed ID: 29940956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of China's Public Hospital Reform on Healthcare Expenditures and Utilization: A Case Study in ZJ Province.
    Zhang H; Hu H; Wu C; Yu H; Dong H
    PLoS One; 2015; 10(11):e0143130. PubMed ID: 26588244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does the leading pharmaceutical reform in China really solve the issue of overly expensive healthcare services? Evidence from an empirical study.
    He Y; Dou G; Huang Q; Zhang X; Ye Y; Qian M; Ying X
    PLoS One; 2018; 13(1):e0190320. PubMed ID: 29338038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of the National Essential Medicines Policy on health expenditures and service delivery in Chinese township health centres: evidence from a longitudinal study.
    Zhang X; Wu Q; Liu G; Li Y; Gao L; Guo B; Fu W; Hao Y; Cui Y; Huang W; Coyte PC
    BMJ Open; 2014 Dec; 4(12):e006471. PubMed ID: 25534214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects on the medical revenue of comprehensive pricing reform in Chinese urban public hospitals after removing drug markups: case of Nanjing.
    Tang W; Xie J; Lu Y; Liu Q; Malone D; Ma A
    J Med Econ; 2018 Apr; 21(4):326-339. PubMed ID: 29139303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Containing medical expenditure: lessons from reform of Beijing public hospitals.
    Liu X; Xu J; Yuan B; Ma X; Fang H; Meng Q
    BMJ; 2019 Jun; 365():l2369. PubMed ID: 31227508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An evaluation of systemic reforms of public hospitals: the Sanming model in China.
    Fu H; Li L; Li M; Yang C; Hsiao W
    Health Policy Plan; 2017 Oct; 32(8):1135-1145. PubMed ID: 28531288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does the separating of hospital revenue from drug sales reduce the burden on patients? Evidence from China.
    Li L; Yu Q
    Int J Equity Health; 2021 Jan; 20(1):12. PubMed ID: 33407503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a typical systemic hospital reform on inpatient expenditure for rural population: the Sanming model in China.
    Meng Z; Zhu M; Cai Y; Cao X; Wu H
    BMC Health Serv Res; 2019 Apr; 19(1):231. PubMed ID: 30992013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of China's healthcare price reforms on traditional Chinese medicine public hospitals in Beijing: an interrupted time-series study.
    Zhu D; Shi X; Nicholas S; Bai Q; He P
    BMJ Open; 2019 Aug; 9(8):e029646. PubMed ID: 31401602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Impact of China's National Essential Medicine Policy and Its Implications for Urban Outpatients: A Multivariate Difference-in-Differences Study.
    Ding L; Wu J
    Value Health; 2017 Mar; 20(3):412-419. PubMed ID: 28292486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of the zero-mark-up drug policy on drug-related expenditures and use in public hospitals, 2016-2018: an interrupted time series study in Shaanxi.
    Yan K; Yang C; Zhang H; Ye D; Liu S; Chang J; Jiang M; Zhao M; Fang Y
    BMJ Open; 2020 Nov; 10(11):e037034. PubMed ID: 33243788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Did the universal zero-markup drug policy lower healthcare expenditures? Evidence from Changde, China.
    Peng Z; Zhan C; Ma X; Yao H; Chen X; Sha X; Coyte PC
    BMC Health Serv Res; 2021 Nov; 21(1):1205. PubMed ID: 34742310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between Primary Healthcare and Medical Expenditures in a Context of Hospital-Oriented Healthcare System in China: A National Panel Dataset, 2012-2016.
    Zhou M; Liao J; Hu N; Kuang L
    Int J Environ Res Public Health; 2020 Sep; 17(18):. PubMed ID: 32971840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effects of County Public Hospital Reform on the Consumption and Costs of Antibiotics: Evidence from a Quasinatural Experiment in Jiangsu, China.
    Wang Y; Zhu Y; Liu X; Xu X; Fang W; Li X
    Biomed Res Int; 2020; 2020():9262170. PubMed ID: 33145360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hong Kong's domestic health spending--financial years 1989/90 through 2004/05.
    Leung GM; Tin KY; Yeung GM; Leung ES; Tsui EL; Lam DW; Tsang CS; Fung AY; Lo SV
    Hong Kong Med J; 2008 Apr; 14 Suppl 2():2-23. PubMed ID: 18587162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the effectiveness of comprehensive drug price reform: a case study from Shihezi city in Western China.
    Lin T; Wu Z; Liu M; Wu X; Zhang X
    Int J Equity Health; 2020 Aug; 19(1):133. PubMed ID: 32762691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.